Catalyst Wire Dossier Catalyst Wire Dossier

Rolapitant

rolapitant · Helsinn Healthcare S.A.
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Rolapitant, covering 2013-11-01 to 2026-03-02. Get the full timeline:

Most recent: Clinical Trial Update: A Cohort Study on the Prevention of Nausea and Vomiting Induced by Concurrent Chemoradiotherapy for Lung Cancer Using Rolapitant and Palonosetron [NA]

See pricing